Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 579

1.

Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis.

Sundin U, Aga AB, Skare Ø, Nordberg LB, Uhlig T, Hammer HB, van der Heijde D, Kvien TK, Lillegraven S, Haavardsholm EA; ARCTIC study group .

Rheumatology (Oxford). 2020 Jan 30. pii: kez674. doi: 10.1093/rheumatology/kez674. [Epub ahead of print]

PMID:
31999341
2.

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.

Michelsen B, Ørnbjerg LM, Kvien TK, Pavelka K, Nissen MJ, Nordström D, Santos MJ, Koca SS, Askling J, Rotar Z, Gudbjornsson B, Codreanu C, Loft AG, Kristianslund EK, Mann HF, Ciurea A, Eklund KK, Vieira-Sousa E, Yazici A, Jacobsson L, Tomšič M, Löve TJ, Ionescu R, van der Horst-Bruinsma IE, Iannone F, Pombo-Suarez M, Jones GT, Hyldstrup LH, Krogh NS, Hetland ML, Østergaard M.

Rheumatology (Oxford). 2020 Jan 20. pii: kez656. doi: 10.1093/rheumatology/kez656. [Epub ahead of print]

PMID:
31960053
3.

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis.

Gladman D, Nash P, Goto H, Birt JA, Lin CY, Orbai AM, Kvien TK.

RMD Open. 2020 Jan;6(1). pii: e000928. doi: 10.1136/rmdopen-2019-000928.

4.

Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study).

Syversen SW, Goll GL, Jørgensen KK, Olsen IC, Sandanger Ø, Gehin JE, Warren DJ, Sexton J, Mørk C, Jahnsen J, Kvien TK, Bolstad N, Haavardsholm EA.

Trials. 2020 Jan 6;21(1):13. doi: 10.1186/s13063-019-3734-4.

5.

Associations between radiographic and ultrasound-detected features in hand osteoarthritis and local pressure pain thresholds.

Steen Pettersen P, Neogi T, Magnusson K, Hammer HB, Uhlig T, Kvien TK, Haugen IK.

Arthritis Rheumatol. 2020 Jan 6. doi: 10.1002/art.41199. [Epub ahead of print]

PMID:
31904188
6.

Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.

Kvamme MK, Lie E, Uhlig T, Moger TA, Kvien TK, Kristiansen IS.

Rheumatology (Oxford). 2019 Dec 22. pii: kez609. doi: 10.1093/rheumatology/kez609. [Epub ahead of print] No abstract available.

PMID:
31865376
7.

Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.

Gehin JE, Goll GL, Warren DJ, Syversen SW, Sexton J, Strand EK, Kvien TK, Bolstad N, Lie E.

Arthritis Res Ther. 2019 Nov 29;21(1):256. doi: 10.1186/s13075-019-2009-5.

8.

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients.

Roelsgaard IK, Ikdahl E, Rollefstad S, Wibetoe G, Esbensen BA, Kitas GD, van Riel P, Gabriel S, Kvien TK, Douglas K, Wållberg-Jonsson S, Rantapää Dahlqvist S, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon CA, Pascual-Ramos V, Contreras-Yáñez I, Sfikakis PP, González-Gay MA, Crowson CS, Semb AG.

Rheumatology (Oxford). 2019 Nov 28. pii: kez557. doi: 10.1093/rheumatology/kez557. [Epub ahead of print]

PMID:
31782789
9.

Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor.

Hammer HB, Kvien TK, Terslev L.

RMD Open. 2019 Oct 17;5(2):e001076. doi: 10.1136/rmdopen-2019-001076. eCollection 2019. No abstract available.

10.

Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?

Mongin D, Lauper K, Turesson C, Hetland ML, Klami Kristianslund E, Kvien TK, Santos MJ, Pavelka K, Iannone F, Finckh A, Courvoisier DS.

RMD Open. 2019 Oct 17;5(2):e000994. doi: 10.1136/rmdopen-2019-000994. eCollection 2019.

11.

Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA.

Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, Santos MJ, Reino JG, Nordström D, Rotar Z, Gudbjornsson B, Onen F, Codreanu C, Lindström U, Möller B, Kvien TK, Pavelka K, Barcelos A, Sánchez-Piedra C, Eklund KK, Tomšič M, Love TJ, Can G, Ionescu R, Loft AG, van der Horst-Bruinsma IE, Macfarlane GJ, Iannone F, Hyldstrup LH, Krogh NS, Østergaard M, Hetland ML.

Rheumatology (Oxford). 2019 Oct 30. pii: kez427. doi: 10.1093/rheumatology/kez427. [Epub ahead of print]

PMID:
31665497
12.

What do we measure with 28-joint DAS in elderly patients? An explorative analysis in the NOR-DMARD study.

van Onna M, Putrik P, Lie E, Kvien TK, Boonen A, Uhlig T.

Rheumatology (Oxford). 2019 Oct 26. pii: kez490. doi: 10.1093/rheumatology/kez490. [Epub ahead of print]

PMID:
31665481
13.

Psychometric performance of the PAncreatic CAncer disease impact (PACADI) score.

Heiberg T, Baekelandt B, Kvien TK, Buanes T.

Pancreatology. 2019 Oct;19(7):971-978. doi: 10.1016/j.pan.2019.09.001. Epub 2019 Sep 2.

14.

Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study.

Provan SA, Lillegraven S, Sexton J, Angel K, Austad C, Haavardsholm EA, Kvien TK, Uhlig T.

Rheumatology (Oxford). 2020 Mar 1;59(3):505-512. doi: 10.1093/rheumatology/kez371.

PMID:
31504942
15.

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration.

Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, Kristianslund EK, Nordström D, Santos MJ, Codreanu C, Gómez-Reino J, Rotar Z, Gudbjornsson B, Di Giuseppe D, Nissen MJ, Pavelka K, Birlik M, Kvien T, Eklund KK, Barcelos A, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Loft AG, van der Horst-Bruinsma I, Jones G, Iannone F, Hyldstrup L, Krogh NS, Hetland ML, Østergaard M.

Ann Rheum Dis. 2019 Nov;78(11):1536-1544. doi: 10.1136/annrheumdis-2019-215427. Epub 2019 Aug 20.

PMID:
31431486
16.

Associations between ultrasound-detected synovitis, pain and function in interphalangeal and thumb base osteoarthritis: Data from the Nor-Hand study.

Fjellstad CM, Mathiessen A, Slatkowsky-Christensen B, Kvien TK, Hammer HB, Haugen IK.

Arthritis Care Res (Hoboken). 2019 Aug 17. doi: 10.1002/acr.24047. [Epub ahead of print]

PMID:
31421023
17.

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis.

Provan SA, Rollefstad S, Ikdahl E, Mathiessen A, Berg IJ, Eeg I, Wilkinson IB, McEniery CM, Kvien TK, Hammer HB, Østerås N, Haugen IK, Semb AG.

BMC Rheumatol. 2019 Aug 8;3:33. doi: 10.1186/s41927-019-0081-8. eCollection 2019.

18.

Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study.

Michelsen B, Sexton J, Wierød A, Bakland G, Rødevand E, Krøll F, Kvien TK.

Semin Arthritis Rheum. 2020 Feb;50(1):12-16. doi: 10.1016/j.semarthrit.2019.07.003. Epub 2019 Jul 12.

PMID:
31358361
19.

Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis.

Lauper K, Mongin D, Iannone F, Kristianslund EK, Kvien TK, Nordström DC, Pavelka K, Pombo-Suarez M, Rotar Z, Santos MJ, Codreanu C, Lukina G, Gale SL, John M, Luder Y, Courvoisier DS, Gabay C.

Semin Arthritis Rheum. 2020 Feb;50(1):17-24. doi: 10.1016/j.semarthrit.2019.06.020. Epub 2019 Jun 28.

20.

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.

Curtis JR, Mariette X, Gaujoux-Viala C, Blauvelt A, Kvien TK, Sandborn WJ, Winthrop K, de Longueville M, Huybrechts I, Bykerk VP.

RMD Open. 2019 May 31;5(1):e000942. doi: 10.1136/rmdopen-2019-000942. eCollection 2019.

Supplemental Content

Loading ...
Support Center